Cirrhosis, highly prevalent worldwide, develops after years of hepatic inflammation
triggering progressive fibrosis. Currently, the main etiologies of cirrhosis are non‐alcoholic …

Non-alcoholic fatty liver disease is a very common medical condition, driven by a
combination of genetic and lifestyle factors, ultimately producing a severe chronic liver …

Nonalcoholic fatty liver disease (NAFLD) and diabetes mellitus are common diseases that
often coexist and might act synergistically to increase the risk of hepatic and extra-hepatic …

Metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed non-
alcoholic fatty liver disease (NAFLD), is defined as steatotic liver disease (SLD) in the …

Abstract Introduction Non-Alcoholic Steatohepatitis (NASH) is a chronic, progressive
disease characterized by fatty liver and liver cell injury, advancing to fibrosis, cirrhosis and …

Background Screening is an important part of preventive medicine. Ideally, screening tools
identify patients early enough to provide treatment and avoid or reduce symptoms and other …

Nonalcoholic fatty liver disease (NAFLD) is becoming a frequent liver disease, especially in
patients with metabolic syndrome and especially in Western countries. Complications of …

Non-alcoholic fatty liver disease (NAFLD) is considered to be the hepatic manifestation of
the metabolic syndrome and is characterized by ectopic accumulation of triglycerides in the …

Background: Non-alcoholic Fatty Liver Disease (NAFLD) is growing more prevalent
worldwide. Although non-invasive diagnostic approaches such as conventional …

Metabolic dysfunction-associated steatotic liver disease (MASLD), previously termed non-
alcoholic fatty liver disease (NAFLD), is defined as steatotic liver disease (SLD) in the …